ATProtect™ Duska is developing ATProtect™ as an novel oral formulation for the protection of humans from the effects of ionizing radiation. Duska is developing a novel formulation of exogenous adenosine 5’-triphosphate (ATP) that has been shown in numerous in vivo studies using several animal species to protect the organism from damage caused by different types of ionic radiation including X ray, gamma, neutron and isotopes. ATProtect™ is being developed as a unique proprietary delivery system of exogenous ATP.

Copyright © 2008 Duska Therapeutics, Inc. 1999-2008 All rights reserved.

 

Duska Therapeutics

info@duskatherapeutics.com

Promising New Medicines